Viewray (NASDAQ:VRAY) Announces Quarterly Earnings Results

Viewray (NASDAQ:VRAY) announced its quarterly earnings data on Thursday. The company reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.23) by ($0.09), Bloomberg Earnings reports. Viewray had a negative net margin of 128.13% and a negative return on equity of 62.98%. The firm had revenue of $30.17 million for the quarter, compared to the consensus estimate of $25.92 million. During the same period last year, the company posted ($0.30) earnings per share. Viewray’s revenue for the quarter was up 83.5% on a year-over-year basis. Viewray updated its FY 2019 guidance to EPS.

Viewray stock opened at $3.10 on Friday. Viewray has a one year low of $2.76 and a one year high of $10.73. The stock has a fifty day moving average of $8.69. The company has a quick ratio of 3.21, a current ratio of 4.28 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $653.46 million, a price-to-earnings ratio of -3.16 and a beta of 0.79.

In related news, insider James F. Dempsey sold 5,146 shares of the stock in a transaction on Monday, July 1st. The stock was sold at an average price of $8.63, for a total value of $44,409.98. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider James F. Dempsey sold 21,615 shares of the stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $8.97, for a total value of $193,886.55. The disclosure for this sale can be found here. 15.48% of the stock is owned by company insiders.

Several equities analysts have weighed in on the company. Mizuho reissued a “buy” rating and set a $9.00 price objective on shares of Viewray in a report on Sunday. Jefferies Financial Group cut their price target on Viewray from $14.00 to $7.00 and set a “buy” rating for the company in a report on Friday. Piper Jaffray Companies assumed coverage on Viewray in a report on Tuesday, June 18th. They issued an “overweight” rating and a $15.00 price target for the company. TheStreet lowered Viewray from a “c-” rating to a “d” rating in a report on Friday, May 3rd. Finally, ValuEngine lowered Viewray from a “buy” rating to a “hold” rating in a report on Saturday. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $11.95.

Viewray Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Further Reading: Gross Domestic Product (GDP)

Earnings History for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit